Atlas Trials

Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer

Clinical trial NCT01175694 · UNKNOWN

Trial details

NCT number
NCT01175694
Sponsor
University Hospital Erlangen
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-01-01
Primary completion
2012-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.